Aspen RxHealth Raises $23M Series B Funding Round Led by Bessemer Venture Partners
Aspen RxHealth, developer of a first-of-its-kind clinical pharmacy model developed by pharmacists for pharmacists that delivers value for health plans and risk-bearing providers, today announced the closure of a $23 million Series B funding round led by Bessemer Venture Partners, with participation from other strategic investors including McKesson Ventures, Novartis, and Takeda Digital Ventures. Previous investors Humana and Flare Capital Partners also participated. The funding will help Aspen RxHealth capitalize on the demand for its highly diverse community of pharmacists and poise the company for successful...